Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3-/- mice

Molecular Immunology

Volumn 50, Issue 1-2, 2012, Pages 9-17

  Caminschi, Irina ^a   Vremec, David ^a   Ahmet, Fatma ^a   Lahoud, Mireille H ^a   Villadangos, Jose A ^a   Murphy, Kenneth M ^c   Heath, William R ^b   Shortman, Ken ^a,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Batf3; Dendritic cells; Targeting Clec9A

Indexed keywords

CD8 ANTIGEN; CELL SURFACE PROTEIN; CLEC9A PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CONTROLLED STUDY; DENDRITIC CELL; HELPER CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; ANTIGENS, CD8; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON REGULATORY FACTORS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, IMMUNOLOGIC; REPRESSOR PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

MUS;

EID: 84857036635     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.11.008     Document Type: Article

References (34)

1. + dendritic cells. Blood 2003, 101:305-310.
2. + dendritic cells. J. Exp. Med. 2010, 207:1273-1281.
3. + dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14745-14750.
4. + dendritic cells capable of inducing antiviral T cell responses. J. Immunol. 2009, 182:4200-4207.
5. + dendritic cells. Nat. Immunol. 2009, 10:488-495.
6. Caminschi I., Proietto A.I., Ahmet F., Kitsoulis S., Shin Teh J., Lo J.C., Rizzitelli A., Wu L., Vremec D., van Dommelen S.L., Campbell I.K., Maraskovsky E., Braley H., Davey G.M., Mottram P., van de Velde N., Jensen K., Lew A.M., Wright M.D., Heath W.R., Shortman K., Lahoud M.H. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008, 112:3264-3273.
7. + T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 2006, 177:2276-2284.
8. + dendritic cells. J. Exp. Med. 2010, 207:1283-1292.
9. + type. J. Immunol. 2011.
10. + dendritic cells [corrected]. J. Immunol. 2011, 186:1503-1511.
11. + T cells. J. Immunol. 2007, 178:6861-6866.
12. den Haan J.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000, 192:1685-1696.
13. + pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 2011, 208:1789-1797.
14. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H.W., Park C.G., Steinman R.M., Nussenzweig M.C. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315:107-111.
15. Edelson B.T., Bradstreet T., Kc W., Hildner K., Herzog J.W., et al. Batf3-dependent CD11b low/2 peripheral dendritic cells are GM-CSF-independent and re not required for Th cell priming after subcutaneous immunization. PLoS One 2011, 6(10):e25660.
16. + conventional dendritic cells. J. Exp. Med. 2010, 207:823-836.
17. + DCs. J. Exp. Med. 2009, 206:3115-3130.
18. + dendritic cells in cytotoxic T cell immunity. Science 2008, 322:1097-1100.
19. + dendritic cells and a subset of monocytes. J. Biol. Chem. 2008, 283:16693-16701.
20. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 2002, 195:1289-1302.
21. + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 2010, 207:1247-1260.
22. + T cell responses. PLoS One 2009, 4:e4204.
23. Lahoud M.H., Ahmet F., Kitsoulis S., Wan S.S., Vremec D., Lee C.N., Phipson B., Shi W., Smyth G.K., Lew A.M., Kato Y., Mueller S.N., Davey G.M., Heath W.R., Shortman K., Caminschi I. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J. Immunol. 2011, 187:842-850.
24. Mittag D., Proietto A.I., Loudovaris T., Mannering S.I., Vremec D., Shortman K., Wu L., Harrison L.C. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J. Immunol. 2011, 186:6207-6217.
25. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., Shortman K. Intrasplenic steady-state dendritic cell precursors which are distinct from monocytes. Nat. Immunol. 2006, 7:663-671.
26. + Dendritic cells. J. Immunol. 2001, 166:5327-5330.
27. Sancho D., Joffre O.P., Keller A.M., Rogers N.C., Martinez D., Hernanz-Falcon P., Rosewell I., Reis e Sousa C. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009, 458:899-903.
28. Sancho D., Mourao-Sa D., Joffre O.P., Schulz O., Rogers N.C., Pennington D.J., Carlyle J.R., Reis e Sousa C. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest. 2008, 118:2098-2110.
29. Sathe P., Pooley J., Vremec D., Mintern J., Jin J.O., Wu L., Kwak J.Y., Villadangos J.A., Shortman K. The acquisition of antigen cross-presentation function by newly formed dendritic cells. J. Immunol. 2011, 186:5184-5192.
30. Schiavoni G., Mattei F., Sestili P., Borghi P., Venditti M., Morse H.C., Belardelli F., Gabriele L. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J. Exp. Med. 2002, 196:1415-1425.
31. Tsujimura H., Tamura T., Gongora C., Aliberti J., Reis e Sousa C., Sher A., Ozato K. ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro. Blood 2003, 101:961-969.
32. Vremec D., O'Keeffe M., Hochrein H., Fuchsberger M., Caminschi I., Lahoud M., Shortman K. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood 2007, 109:1165-1173.
33. Vremec D., Pooley J., Hochrein H., Wu L., Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 2000, 164:2978-2986.
34. Zhan Y., Carrington E.M., van Nieuwenhuijze A., Bedoui S., Seah S., Xu Y., Wang N., Mintern J.D., Villadangos J.A., Wicks I.P., Lew A.M. GM-CSF increases cross-presentation and CD103 expression by mouse CD8 spleen dendritic cells. Eur. J. Immunol. 2011, 41:2585-2595.